Skip to main content

Table 4 Patient and hospital factors associated with outcomes following surgical resection

From: Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data

 

C15

C15 & C16.0

Outcome

N (Rate per 100)

aOR (95%CI)#

N (Rate per 100)

aOR (95%CI)#

(i) Length-of-stay >28 days

105 (20.9)

 

186 (19.7)

 

<60 years

23 (14.0)

0.20 (0.08-0.53)*

43 (14.3)

0.24 (0.12-0.51)*

60–64 years

43 (22.1)

0.41 (0.17-1.00)

67 (20.2)

0.43 (0.22-0.87)*

70–74 years

28 (24.1)

0.44 (0.17-1.13)

60 (25.4)

0.57 (0.28-1.17)

80+ years

11 (39.3)

Referent

16 (34.8)

Referent

Australian born

75 (21.7)

Referent

133 (20.9)

Referent

Overseas born

30 (19.0)

0.62 (0.38-1.05)

53 (19.0)

0.67 (0.46-0.99)*

Private co-located

14 (14.4)

Referent

22 (12.8)

Referent

Private non co-located

11 (12.2)

1.06 (0.43-2.63)

23 (13.0)

1.92 (0.90-4.13)

Public co-located

43 (23.6)

1.61 (0.74-3.49)

71 (22.7)

2.10 (1.17-3.78)*

Public non co-located

37 (27.6)

3.16 (0.98-10.8)

70 (27.7)

7.89 (3.16-19.5)*

Area 1

29 (29.3)

0.91 (0.26-3.18)

52 (27.5)

0.44 (0.17-1.10)

Area 2

22(20.6)

0.91 (0.43-1.96)

43 (22.4)

1.24 (0.70-2.19)

Area 3

22 (23.7)

Referent

37 (22.7)

Referent

Area 4

21 (16.7)

0.74 (0.33-1.66)

33 (15.3)

0.64 (0.34-1.20)

Area 5

8 (15.1)

0.30 (0.07-1.26)

14 (13.5)

0.15 (0.05-0.43)*

Area 6

2 (18.2)

0.82 (0.12-5.59)

3 (15.0)

0.30 (0.07-1.39)

Area 7

1 (7.1)

0.18 (0.02-1.92)

4 (12.9)

0.22 (0.06-0.86)*

(ii) 30 day complication

108 (21.5)

 

168 (17.0)

 

<60 years

35 (21.3)

0.40 (0.17-0.98)*

53 (17.6)

0.53 (0.26-1.10)

60–64 years

36 (18.5)

0.33 (0.14-0.80)*

59 (17.8)

0.55 (0.27-1.13)

70–74 years

25 (21.6)

0.39 (0.16-0.99)*

52 (22.0)

0.70(0.34-1.46)

80+ years

12 (42.9)

Referent

14 (30.4)

Referent

Australian born

71 (20.6)

Referent

129 (20.3)

Referent

Overseas born

37 (23.4)

1.28 (0.79-2.08)

49 (17.6)

0.87 (0.92-1.06)

Private co-located

16 (16.5)

Referent

28 (16.3)

Referent

Private non co-located

22 (24.4)

1.13 (0.43-2.98)

32 (18.1)

1.07 (0.51-2.23)

Public co-located

40 (22.0)

1.82 (0.87-3.78)

61 (19.5)

1.37 (0.79-2.40)

Public non co-located

30 (22.4)

0.74 (0.23-2.37)

57 (22.5)

1.47 (0.62-3.49)

Area 1

25 (25.3)

3.88 (1.12-13.5)*

40 (21.2)

1.36 (0.54-3.47)

Area 2

21 (19.6)

1.91 (0.85-4.28)

37 (19.3)

1.40 (0.76-2.57)

Area 3

15 (16.1)

Referent

28 (17.2)

Referent

Area 4

29 (23.0)

2.24 (0.99-5.09)

40 (18.5)

1.29 (0.68-2.42)

Area 5

13 (24.5)

4.01 (1.04-15.4)*

23 (22.1)

1.34 (0.49-3.65)

Area 6

9 (18.2)

2.86 (0.43-19.1)

2 (10.0)

0.74 (0.14-3.97)

Area 7

11 (21.4)

3.87 (0.68-22.1)

8 (25.8)

2.14 (0.66-6.91)

 

Mortality N (rate per 100)

aHR (95%CI)

Mortality N (rate per 100)

aHR (95%CI)

(iv) One year survival

123 (24.5)

 

218 (23.1)

 

<60 years

36 (22.0)

0.20 (0.10-0.41)*

64 (21.3)

0.41 (0.23-0.74)*

60–64 years

38 (30.9)

0.19 (0.09-0.38)*

65 (19.6)

0.36 (0.20-0.65)*

70–74 years

32 (27.6)

0.22 (0.10-0.47)*

68 (28.8)

0.44 (0.24-0.81)*

80+ years

17 (60.7)

Referent

21 (45.6)

Referent

Australian born

90 (26.1)

Referent

155 (24.4)

Referent

Overseas born

33 (20.9)

0.64 (0.39-1.06)

63 (22.6)

0.74 (0.51-1.08)

Private co-located

10 (10.3)

Referent

20 (11.6)

Referent

Private non co-located

22 (24.4)

1.58 (0.57-4.42)

40 (22.6)

2.20 (1.03-4.70)*

Public co-located

48 (26.4)

1.25 (0.55-2.83)

80 (25.6)

1.80 (0.97-3.32)

Public non co-located

43 (32.1)

1.34 (0.45-4.02)

78 (30.8)

1.66 (0.71-3.89)

Area 1

34 (34.3)

1.06 (0.36-3.16)

61 (32.3)

1.28 (0.54-3.03)

Area 2

23 (21.5)

0.93 (0.42-2.04)

41 (21.4)

1.08 (0.60-1.96)

Area 3

25 (26.9)

Referent

38 (23.3)

Referent

Area 4

19 (15.1)

0.73 (0.32-1.68)

38 (17.6)

0.93 (0.49-1.76)

Area 5

15 (28.3)

0.85 (0.26-2.82)

30 (28.9)

1.67 (0.67-4.11)

Area 6

2 (18.2)

1.52 (0.27-8.52)

5 (25.0)

1.92 (0.59-6.22)

Area 7

5 (35.7)

1.45 (0.36-5.87)

5 (16.1)

0.76 (0.22-2.66)

  1. # Adjusted for age-group, gender, histology, country of birth, degree-of-spread, tumour location, hospital admitted, area of service, Charlson comorbidity index, surgery type.
  2. * Significant at the P<0.05 (two-tailed) level.